BREAST INFLAMMATORY CARCINOMA
Clinical trials for BREAST INFLAMMATORY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BREAST INFLAMMATORY CARCINOMA trials appear
Sign up with your email to follow new studies for BREAST INFLAMMATORY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy boost for tough breast cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard hormone therapy can help prevent recurrence in people with a rare, aggressive type of breast cancer called inflammatory breast cancer. Participants had hormone receptor-positive cancer that did not f…
Matched conditions: BREAST INFLAMMATORY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New combo therapy aims to stop aggressive breast cancer
Disease control OngoingThis study tests whether adding the targeted drug olaparib to standard radiation therapy helps prevent inflammatory breast cancer from coming back. Inflammatory breast cancer is a rare and aggressive form of the disease. About 300 patients who have already had chemotherapy and su…
Matched conditions: BREAST INFLAMMATORY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 08, 2026 13:18 UTC